gizpe86

Gizeh Perez-Tenorio

Principal Research Engineer, Docent

Publications

2024

Josefine Sandström, Jens Bomanson, Gizeh Perez-Tenorio, Carolin Jönsson, Bo Nordenskjöld, Tommy Fornander, Linda S. Lindstrom, Olle Stål (2024) GATA3 and markers of epithelial-mesenchymal transition predict long-term benefit from tamoxifen in ER-positive breast cancer npj Breast Cancer, Vol. 10, Article 78 (Article in journal) Continue to DOI

2022

Annelie Johansson, Huma Dar, Laura J. van t Veer, Nicholas P. Tobin, Gizeh Perez-Tenorio, Anna Nordenskjöld, Ulla Johansson, Johan Hartman, Lambert Skoog, Christina Yau, Christopher C. Benz, Laura J. Esserman, Olle Stål, Bo Nordenskjöld, Tommy Fornander, Linda S. Lindstrom (2022) Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical Trial Journal of Clinical Oncology, Vol. 40, p. 4071-4082 (Article in journal) Continue to DOI
Jenny Pousette, Annelie Johansson, Carolin Jönsson, Tommy Fornander, Linda S. Lindström, Hans Olsson, Gizeh Perez-Tenorio (2022) Prognostic and Predictive Significance of Stromal Tumor-Infiltrating Lymphocytes (sTILs) in ER-Positive/HER2-Negative Postmenopausal Breast Cancer Patients Cancers, Vol. 14, Article 4844 (Article in journal) Continue to DOI
Annelie Johansson, Nancy Y. Yu, Adina Iftimi, Nicholas P. Tobin, Laura Van 'T Veer, Bo Nordenskjöld, Christopher C. Benz, Tommy Fornander, Gizeh Pérez-Tenorio, Olle Stål, Laura J. Esserman, Christina Yau, Linda S. Lindström (2022) Clinical and molecular characteristics of estrogen receptor-positive ultralow risk breast cancer tumors identified by the 70-gene signature International Journal of Cancer, Vol. 150, p. 2072-2082 (Article in journal) Continue to DOI

2021

Huma Dar, Annelie Johansson, Anna Nordenskjöld, Adina Iftimi, Christina Yau, Gizeh Perez-Tenorio, Christopher Benz, Bo Nordenskjöld, Olle Stål, Laura J. Esserman, Tommy Fornander, Linda S. Lindström (2021) Assessment of 25-Year Survival of Women With Estrogen Receptor-Positive/ERBB2-Negative Breast Cancer Treated With and Without Tamoxifen Therapy A Secondary Analysis of Data From the Stockholm Tamoxifen Randomized Clinical Trial JAMA Network Open, Vol. 4, Article e2114904 (Article in journal) Continue to DOI